Skip to content

Clinical Study on the Application of Bupivacaine Liposomes for Postoperative Pain Relief in Thoracoscopic Cardiac Surgery

Clinical Study on the Application of Bupivacaine Liposomes for Postoperative Pain Relief in Thoracoscopic Cardiac Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124337
Enrollment
Unknown
Registered
2026-05-11
Start date
2026-05-11
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracoscopic cardiac surgery

Interventions

General anesthesia combined with intercostal nerve block group:Fifteen minutes after the patient had undergone general anesthesia, the same anesthesiologist with extensive experience in ultrasound-gui
Group with general anesthesia combined with local infiltration.:After the patient’s surgery and before skin suturing, the operating surgeon administers local infiltration of bupivacaine liposomes (133

Sponsors

Xiamen University Affiliated Cardiovascular Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18-65 years old; 2. Selective thoracoscopic cardiac surgery; 3. Preoperative NRS score <= 1, no history of chronic pain; 4. Informed consent from patients and their families. ?

Exclusion criteria

Exclusion criteria: 1. Allergic to bupivacaine liposomes or local anesthetics; 2. Coagulation dysfunction; 3. Infection, deformity or pleural adhesions at the puncture site; 4. Severe liver and kidney dysfunction; 5. Cognitive impairment or inability to cooperate with assessment; 6. Pregnant/lactating women; 7. Individuals who have used long-acting local anesthetics or opioid drugs in the past month.

Design outcomes

Primary

MeasureTime frame
NRS scores for postoperative rest and coughing.;

Secondary

MeasureTime frame
Daily opioid medication dosage post-surgery (converted to morphine equivalent dose).;Time required for the first instance of self-administered pain relief.;QoR-15 score 24 hours post-surgery.;Incidence of perioperative adverse events (e.g., nausea, vomiting, constipation, drowsiness).;Length of stay in the ICU.;Total hospital stay time.;Levels of inflammatory factors TNF-a, IL-6, and IL-1ß in the serum before surgery, 24 hours after surgery, and 72 hours after surgery.;

Countries

China

Contacts

Public ContactYan Pianpian

Xiamen University Affiliated Cardiovascular Hospital

64891809@qq.com+86 134 5901 5570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026